QliniQ Acquired by Marksans Pharma | Healthcare M&A Deal

Marksans Pharma has acquired QliniQ, a healthcare services other business in the Netherlands, for $7.5m. QliniQ B.V. provides healthcare services and supports delivery of medical care across the EU market from its Dutch base. Marksans Pharma acquisitions aim to strengthen EU reach through a healthcare services other acquisition and broaden service capabilities in the Netherlands. This strategic acquisition is structured as an add on acquisition, with Marksans Pharma as a strategic buyer pursuing healthcare M&A under $10m; deal status is announced and terms are not disclosed.